Ledger.Open graph →
SEC Form D · filed December 18, 2025

Delfi Diagnostics, Inc

Offering
$60.0M
Sold
$34.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Palo Alto, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (22)

Victor B. Velculescu · Palo Alto, CADirectorElizabeth B. Homans · Palo Alto, CADirectorRishi B. Gupta · Palo Alto, CADirectorMichael B. Dybbs · Palo Alto, CADirectorGreg B. Yap · Palo Alto, CADirectorJustin B. Kao · Palo Alto, CADirectorPeter B. Bach · Palo Alto, CAExecLee-Ann B. Smith-Freeman · Palo Alto, CAExecSusan Tousi · Palo Alto, CAExec · DirectorAmoolya B. Singh · Palo Alto, CAExecJacob B. Van Naarden · Palo Alto, CADirectorVictor B. Velculescu · Palo Alto, CADirectorPeter B. Bach · Palo Alto, CAExecLee-Ann B. Smith-Freeman · Palo Alto, CAExecSusan Tousi · Palo Alto, CAExec · DirectorAmoolya B. Singh · Palo Alto, CAExecElizabeth B. Homans · Palo Alto, CADirectorRishi B. Gupta · Palo Alto, CADirectorJacob B. Van Naarden · Palo Alto, CADirectorMichael B. Dybbs · Palo Alto, CADirectorGreg B. Yap · Palo Alto, CADirectorJustin B. Kao · Palo Alto, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗